Skip to main content

Table 2 Prevalence of comorbidities in systemic sclerosis (SSc) and rheumatoid arthritis (RA) matched cohorts

From: Prevalence of comorbidities in systemic sclerosis versus rheumatoid arthritis: a comparative, multicenter, matched-cohort study

Comorbidity

SSc

RA

Crude OR

Adjusted OR

Diabetes mellitus

23 (5.6)

48 (11.8)

0.45 (0.27–0.75)

–

Dyslipidemia

72 (17.7)

123 (30.2)

0.50 (0.36–0.69)

–

Arterial hypertension

131 (32.1)

125 (30.6)

1.07 (0.80–1.44)

–

Coronary event

11 (2.7)

15 (3.7)

0.73 (0.33–1.60)

0.74 (0.34–1.62)*

Stroke

8 (1.9)

14 (3.4)

0.56 (0.23–1.35)

0.55 (0.21–1.32)*

Ischemic stroke

5 (1.2)

12 (2.9)

0.40 (0.14–1.17)

0.39 (0.14–1.15)

Hemorrhagic stroke

3 (0.7)

2 (0.5)

1.5 (0.25–9.04)

1.48 (0.23–8.96)

Neoplasia

17 (4.2)

19 (4.7)

0.89 (0.46–1.74)

–

Chronic obstructive pulmonary disease

21 (5.2)

15 (3.7)

1.42 (0.72–2.80)

1.46 (0.74–2.90)**

Osteoporosis

98 (24.0)

92 (22.6)

1.09 (0.79–1.50)

1.08 (0.78–1.49)***

Depression

90 (22.1)

49 (12)

2.07 (1.42–3.03)

–

  1. All data are shown as number (percentage)
  2. OR odds ratio
  3. *Adjusted for smoking, corticosteroid treatment, arterial hypertension, dyslipidemia
  4. **Adjusted for smoking
  5. ***Adjusted for corticosteroid treatment